600535:SHA
Tasly Pharmaceutical Group Co Ltd
CN¥ 14,09
0,00%
(0,00) 1D
15 okt, 15:00:00 GMT+8 · CNY
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor 600535 genereren…
Beursw.
20,87Â mld.
Gem. vol.
11,45Â mln.
Volume
0,00
Dividend
2,41%
Kwartaaldividend
CN¥ 0,09
Ex-dividenddatum
29 mei 2026
Koers/winst-verhouding
17,21
52 wk hoog
CN¥ 16,24
52 wk laag
CN¥ 12,90
WPA
CN¥ 0,82
Uitstaande aandelen
1,51Â mld.
Aantal medewerkers
11K
Beursw.
20,87Â mld.
Gem. vol.
11,45Â mln.
Volume
0,00
Dividend
2,41%
Kwartaaldividend
CN¥ 0,09
Ex-dividenddatum
29 mei 2026
Koers/winst-verhouding
17,21
52 wk hoog
CN¥ 16,24
52 wk laag
CN¥ 12,90
WPA
CN¥ 0,82
Uitstaande aandelen
1,51Â mld.
Aantal medewerkers
11K
Nieuwsartikelen
Van webbronnen en nieuwspartners
MarketScreener Nederland
·
5 uur geleden
S&P 500 sluit hoger nu handelaren de overstap maken van AI naar gezondheidszorg
MarketScreener Nederland
·
5 uur geleden
Wereldwijde aandelenmarkten onveranderd nu zorgen over AI en rente op technologie drukken
MarketScreener Nederland
·
12 uur geleden
VS: index van de New York Fed overtreft de verwachtingen ruimschoots
Profiel
Tasly is a Chinese pharmaceutical company based in the city of Tianjin. It was established in 1994 and is notably producing traditional Chinese medicines.
It has a turnover of 4 billion US dollars, 10,000 employees and is listed on the Shanghai Stock Exchange.
In 2009, Chinese pharmacologist Li Lianda claimed that a key product made by Tasly was unsafe. Tasly sued Li in 2013, alleging that Li's claim was baseless and was motivated by his financial and employment relations with Guangzhou Pharmaceutical, a direct competitor of Tasly. In September 2014, the Tianjin High People's Court ruled in favour of Tasly and ordered Li to issue an apology and pay Tasly 300,000 yuan in compensation.
In February 2017, Tasly announced plans to form a joint venture with American multi-level marketing company Herbalife. Wikipedia
Over Tasly Pharmaceutical Group Co Ltd